Tag: Sickle-Cell Anemia
ASH: Lower Rate of Sickle Cell Pain Crises With Crizanlizumab
Lower rate of crises per year; longer median time to first, second crises with high-dose therapy
Sickle Cell Trait Doesn’t Up Mortality Risk in U.S. Soldiers
However, SC trait was linked with significantly higher risk of exertional rhabdomyolysis
ATS: Hydroxyurea Can Up Lung Function in Sickle Cell Disease
Drug slowed down the annual decline children had been showing before starting treatment
ASH: Prasugrel Doesn’t Cut Vaso-Occlusive Crisis in Sickle Cell
Rate of vaso-occlusive crisis events is not lower for children receiving prasugrel versus placebo
Hydroxyurea Underutilized for Patients With Sickle Cell
Only 23 percent using the drug within a year of their last pain crisis
